MedTech Acquisition Corp
MedTech Acquisition Corp (MTAC) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 11 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jun 26, 2023 involved a transaction of 6,249,999 shares valued at $0.
MTAC Insider Activity Summary
Who Is Buying MTAC Stock?
No significant insider buying has been recorded for MTAC in the recent period.
Who Is Selling MTAC Stock?
No significant insider selling has been recorded for MTAC in the recent period.
Is MedTech Acquisition Corp Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MTAC is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
MTAC Frequently Asked Questions
Understanding MTAC Insider Activity
Insider trading at MedTech Acquisition Corp (MTAC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading MTAC stock, having executed 11 transactions in the past 90 days. The most active insider is David J. Snyderman (Executive), who has made 10 transactions totaling $4.7M.
Related Tools
Track MedTech Acquisition Corp Insider Activity
Get notified when executives and directors at MTAC file new Form 4 transactions